A consultation with our team can determine if its right for you
This peptide is generally considered safe for clinical use, with most subjects not experiencing adverse effects
Anecdotal reports of subcutaneous use exist, but no formal stability, bioavailability, or safety data supports this route
The molecule is identical to the vial variant
It contains 0.9% benzyl alcohol which inhibits bacterial growth, allowing for safer and longer preservation of your research peptide solutions
Sikiric, P., Drmic, D., Sever, M., Klicek, R., Blagaic, A., Tvrdei, A., Kralj, T., Kovac, K., Vukojevi, J., Siroglavi, M., Gojkovic, S., Krezic, I., Pavlov, K., Rasic, D., Mirkovic, I., Kokot, A., krti, A., & Seiwerth, S